Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05768373 · ClinicalTrials.gov registry record · NA
A Comparison Study of Hypersensitivity Treatment
A NA study of Dentin Hypersensitivity, sponsored by Solventum US.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
- 1
- Study location
NCT05768373 is a NA study of Dentin Hypersensitivity that has completed, run by Solventum US. The registered enrollment target is 101 participants, below the 363-participant average among 4 other Dentin Hypersensitivity trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05768373, a NA study of Dentin Hypersensitivity, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the effect of 3M™ Clinpro™ Fluoride Aqueous Solution (experimental) on Dentin Hypersensitivity (DHS) in comparison to 3M™ Vanish™ (commercialized, control\] in patients who have DHS. Participants will be asked to complete the following activities: Undergo a pre-treatment washout period for 3- to 6-weeks (± 4 days) post-enrollment. During this time, the Subject is to only use the provided oral hygiene products. Hypersensitivity will be assessed prior to (baseline) and immediately after sample application. Subject will be asked to come to the facility for hypersensitivity assessments at 24 hours, 7 days, and 30 days after the treatment visit. Researchers will compare 3M™ Clinpro™ Fluoride Aqueous Solution to 3M™ Vanish™ to evaluate if the effect of Clinpro™ on DHS treatment is non-inferior to Vanish™.
Conditions Studied
Interventions
- DEVICE 3M™ Clinpro™ Fluoride Aqueous Solution
- DEVICE 3M™ Vanish™
Study Locations (1)
California
- LOMA LINDA UNIVERSITY, School of Dentistry - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2023-04-04 |
| Est. Completion | 2023-07-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05768373
The ClinicalTrials.gov registry entry for NCT05768373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 363-participant average among 4 other Dentin Hypersensitivity trials with a reported enrollment target (72% lower). The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dentin Hypersensitivity appearing as the primary indexed condition, and to 2 interventions - of which 3M™ Clinpro™ Fluoride Aqueous Solution is the first listed.
NCT05768373 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05768373 about?
NCT05768373 is a clinical study titled "A Comparison Study of Hypersensitivity Treatment". The goal of this clinical trial is to evaluate the effect of 3M™ Clinpro™ Fluoride Aqueous Solution (experimental) on Dentin Hypersensitivity (DHS) in comparison to 3M™ Vanish™ (commercialized, control\] in patients who have DHS. Participants will be asked to complete the following activities: Und...
What is the current status of trial NCT05768373?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2023-04-04. Estimated completion is 2023-07-14.
What conditions does trial NCT05768373 study?
This clinical trial studies the following conditions: Dentin Hypersensitivity.
What interventions are being tested in trial NCT05768373?
The interventions under investigation include: 3M™ Clinpro™ Fluoride Aqueous Solution (DEVICE), 3M™ Vanish™ (DEVICE).
Who is sponsoring clinical trial NCT05768373?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05768373 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dentin Hypersensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Investigate the Tooth Whitening and Dentin Hypersensitivity Effectiveness of Two Experimental Toothpastes
RECRUITING · NA
-
A Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitivity
COMPLETED · NA
-
Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice
RECRUITING · Phase 3
-
A Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.